The interventional cardiology devices market is a multi-billion-dollar market which includes, but is not limited to, drug-eluting stents, catheters, bare-metal stents, guidewires, and percutaneous transluminal coronary angioplasty. The intervention cardiology devices market provides treatment for a range of cardiovascular diseases including coronary artery disease, peripheral vascular disease, and heart valve disease. The global interventional cardiology devices market is anticipated to expand at a CAGR of 6.04% during the 2018-2023 period, and will reach a value of USD 15.43 Bn by 2023. Rising incidence of cardiovascular diseases, along with the adoption of minimally invasive surgeries is expected to drive the interventional cardiology devices market during the forecast period.
Segmentation based on product type
Based on product type, the drug-eluting stents segment contributed the highest revenue in 2018, by replacing the bare-metal stents market, owing to major technological advancements. The segment is anticipated to register a CAGR of 5.71% during the 2018-2023 period, to reach USD 6.71 Bn by 2023. Catheters being the major medium of interventional cardiology procedures, its segment holds a market share of ~27%. The segment is expected to expand at the highest CAGR (7.02%) during the forecast period.

Regional insights
North America accounted for ~38% of the total revenue of the interventional cardiology devices market in 2018, followed by Asia-Pacific (~27%). The Asia-Pacific region is anticipated to expand at the highest CAGR (6.94%) during the forecast period, followed by Latin America, and the Middle East and Africa, expanding at CAGRs of 6.54% and 6.29% respectively. Most of Asia-Pacific's growth is estimated to come from China, Japan, and India due to the increasing incidence of cardiovascular diseases and rising number of diabetic patients.

Companies profiled
Abbott Laboratories
Boston Scientific Corporation
Medtronic
Terumo Corporation
Edwards Lifesciences Corporation
Becton Dickinson
Johnson & Johnson
B. Braun Melsungen
Teleflex Incorporated
MicroPort Scientific Corporation

Chapter 1: Executive Summary

1.1. Market scope and segmentation

1.2. Key questions answered in the study

1.3. Executive summary

Chapter 2: Introduction

2.1. Market definitions

2.2. Market trends

2.3. Market drivers

2.4. Market challenges

2.5. Revenue based on product type - (USD Bn) (2018)

2.6. Value chain analysis of the global interventional cardiology devices market

Chapter 3: Global interventional cardiology devices market overview

3.1. Market overview

3.1.1. Global historical market revenue (USD Bn) (2016-2017)

3.1.2. Global forecast market revenue (USD Bn) (2018-2023)

3.1.3. Geography-wise market revenue (USD Bn) (2018 and 2023)

Chapter 4: Global interventional cardiology devices market - based on product type

4.1. Drug-eluting stents market

4.1.1. Revenue - (2015, 2018 and 2023) (USD Bn)

4.1.2. Trends

4.1.3. Drivers

4.2. Catheters market

4.2.1. Revenue - (2015, 2018 and 2023) (USD Bn)

4.2.2. Trends

4.2.3. Drivers

4.3. Bare-metal stents market

4.3.1. Revenue - (2015, 2018 and 2023) (USD Bn)

4.3.2. Trends

4.3.3. Drivers

4.4. Guidewires market

4.4.1. Revenue - (2015, 2018 and 2023) (USD Bn)

4.4.2. Trends

4.4.3. Drivers

4.5. Other interventional cardiology devices market

4.5.1. Revenue - (2015, 2018 and 2023) (USD Bn)

4.5.2. Trends

4.5.3. Drivers

Chapter 5: Global interventional cardiology devices market - based on regions

5.1. North America

5.1.1. Overview

5.1.2. Revenue - (2015-2023) (USD Bn)

5.1.3. Key highlights

5.2. Europe

5.2.1. Overview

5.2.2. Revenue - (2015-2023) (USD Bn)

5.2.3. Key highlights

5.3. Asia-Pacific

5.3.1. Overview

5.3.2. Revenue - (2015-2023) (USD Bn)

5.3.3. Key highlights

5.4. Latin America

5.4.1. Overview

5.4.2. Revenue - (2015-2023) (USD Bn)

5.4.3. Key highlights

5.5. The Middle East and Africa

5.5.1. Overview

5.5.2. Revenue - (2015-2023) (USD Bn)

5.5.3. Key highlights

Chapter 6: Market share of companies

6.1. Companies' share in the global interventional cardiology devices market

Chapter 7: Competitive landscape

7.1. Abbott Laboratories

7.1.1. Company snapshot

7.1.2. Key financials

7.1.3. Business description and major products

7.1.4. Global presence

7.1.5. Major initiatives

7.1.6. Growth strategies

Note: Similar information areas will be covered for the competitors

7.2. Boston Scientific Corporation

7.3. Medtronic

7.4. Terumo Corporation

7.5. Edwards Lifesciences Corporation

7.6. Becton Dickinson

7.7. Johnson & Johnson

7.8. B. Braun Melsungen

7.9. Teleflex Incorporated

7.10. MicroPort Scientific Corporation

Chapter 8: Conclusion

8.1. Conclusion

Chapter 9: Appendix

9.1. List of tables

9.2. Assumptions

9.3. Research methodology

9.4. About Research On Global Markets

9.5. Disclaimer

Medical Devices Secondary Packaging Market Size And Share Analysis - Growth Trends And Forecasts (2024-2031)...

The Medical Devices Secondary Packaging Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape,...

Asia Pacific Vascular Closure Devices Market Size, Share, Trends & Analysis by Type (Active Approximators, Passive Approximators, External Hemostatic Devices), by Access (Femoral Access, Radial Access), by Procedure (Interventional Cardiology, Interventional Radiology) and Region, with Forecasts from 2024 to 2034....

Market Overview The Asia Pacific Vascular Closure Devices Market is anticipated to experience substantial growth from 2024 to 2034. The market's expansion is fueled by advancements in vascular closure technologies, increasing prevalence of cardiovascular diseases, and the growing adopti...

Europe Vascular Closure Devices Market Size, Share, Trends & Analysis by Type (Active Approximators, Passive Approximators, External Hemostatic Devices), by Access (Femoral Access, Radial Access), by Procedure (Interventional Cardiology, Interventional Radiology) and Region, with Forecasts from 2024 to 2034....

Market Overview The Europe Vascular Closure Devices Market is poised for significant growth from 2024 to 2034, driven by advancements in minimally invasive procedures, increasing procedural volumes, and a growing preference for vascular closure solutions that enhance patient outcomes. T...

North America Vascular Closure Devices Market Size, Share, Trends & Analysis by Type (Active Approximators, Passive Approximators, External Hemostatic Devices), by Access (Femoral Access, Radial Access), by Procedure (Interventional Cardiology, Interventional Radiology) and Region, with Forecasts from 2024 to 2034....

Market Overview The North America Vascular Closure Devices (VCD) Market is anticipated to witness significant growth from 2024 to 2034, driven by the increasing volume of minimally invasive cardiovascular procedures, rising prevalence of cardiovascular diseases, and advancements in vasc...

Global Vascular Closure Devices Market Size, Share, Trends & Analysis by Type (Active Approximators, Passive Approximators, External Hemostatic Devices), by Access (Femoral Access, Radial Access), by Procedure (Interventional Cardiology, Interventional Radiology) and Region, with Forecasts from 2024 to 2034....

Market Overview The Global Vascular Closure Devices Market is projected to grow substantially from 2024 to 2034, driven by the increasing volume of minimally invasive cardiovascular procedures and the rising demand for fast, efficient vascular closure solutions. In 2024, the market is v...

Asia Pacific Nuclear Medicine Market Size, Share, Trends & Analysis by Product (Diagnostics (SPECT, PET), Therapeutics (Alpha Emitters, Beta Emitters)), by Application (Neurology, Cardiology, Oncology, Others), by End User (Hospitals & Clinics, Diagnostic Centers, Others) and Region, with Forecasts from 2024 to 2034....

Market Overview The Asia Pacific Nuclear Medicine Market is poised for significant growth from 2024 to 2034, driven by advancements in nuclear imaging technologies, increased application in various medical fields, and rising healthcare investments across the region. The market is expect...

Europe Nuclear Medicine Market Size, Share, Trends & Analysis by Product (Diagnostics (SPECT, PET), Therapeutics (Alpha Emitters, Beta Emitters)), by Application (Neurology, Cardiology, Oncology, Others), by End User (Hospitals & Clinics, Diagnostic Centers, Others) and Region, with Forecasts from 2024 to 2034....

Market Overview The Europe Nuclear Medicine Market is expected to witness substantial growth from 2024 to 2034, driven by advancements in nuclear imaging technology, increasing demand for early and accurate diagnosis, and the growing prevalence of chronic diseases such as cancer and car...

North America Nuclear Medicine Market Size, Share, Trends & Analysis by Product (Diagnostics (SPECT, PET), Therapeutics (Alpha Emitters, Beta Emitters)), by Application (Neurology, Cardiology, Oncology, Others), by End User (Hospitals & Clinics, Diagnostic Centers, Others) and Region, with Forecasts from 2024 to 2034....

Market Overview The North America Nuclear Medicine Market is poised for substantial growth between 2024 and 2034, driven by advancements in diagnostic imaging and therapeutic applications, rising prevalence of chronic diseases, and increasing adoption of nuclear medicine techniques. The...

Global Nuclear Medicine Market Size, Share, Trends & Analysis by Product (Diagnostics (SPECT, PET), Therapeutics (Alpha Emitters, Beta Emitters)), by Application (Neurology, Cardiology, Oncology, Others), by End User (Hospitals & Clinics, Diagnostic Centers, Others) and Region, with Forecasts from 2024 to 2034....

Market Overview The Global Nuclear Medicine Market is projected to experience significant growth from 2024 to 2034, driven by technological advancements in diagnostic imaging and the increasing demand for targeted radiopharmaceutical therapies. Valued at USD XX.XX billion in 2024, the m...

Asia Pacific Wi-Fi Chipset Market Size, Share, Trends & Analysis by Band (Single Band, Dual Band, Tri Band), by MIMO Configuration (SU-MIMO, MU-MIMO), by End-Use (Smartphones, Tablets, PCs, Access Point Equipment, Connected Home Devices, Others) and Region, with Forecasts from 2024 to 2034....

Market Overview The Asia Pacific Wi-Fi Chipset Market is on a trajectory of significant expansion from 2024 to 2034, driven by the increasing demand for high-speed wireless connectivity, advancements in Wi-Fi technologies, and the proliferation of connected devices. The market is antici...